Efficacy and safety of efalizumab therapy in two pediatric patients with plaque psoriasis

被引：0
|
作者：
Turner, J [1 ]
机构：
[1] Mid S Dermatol & Skin Canc Ctr, Bartlett, TN USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P183 / P183
页数：1
相关论文
共 50 条
  • [21] Long-term management of plaque psoriasis with continuous efalizumab therapy
    Menter, A
    Leonardi, CL
    Sterry, W
    Bos, JD
    Papp, KA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (04) : S182 - S188
  • [22] Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
    Ribero, Simone
    Licciardello, Matteo
    Quaglino, Pietro
    Dapavo, Paolo
    CASE REPORTS IN DERMATOLOGY, 2019, 11 : 23 - 28
  • [23] Improved efficacy of efalizumab as adjunctive therapy in moderate to severe psoriasis: short term and maintenance safety data in 10 patients
    Mak, R.
    Cerio, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 : 50 - 51
  • [24] Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
    Gisondi P.
    Dalle Vedove C.
    Girolomoni G.
    Dermatology and Therapy, 2014, 4 (1) : 1 - 9
  • [25] Safety and tolerability of efalizumab therapy: 60 weeks results from a phase IIIb trial in moderate-to-severe plaque patients with psoriasis
    Menter, A
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [26] Efficacy and safety of infliximab therapy in plaque psoriasis patients previously treated with etanercept: Analysis of PSUNRISE
    Gottlieb, A. B.
    Wang, Jim
    Chevrier, Marc
    Kalb, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB133 - AB133
  • [27] Secukinumab efficacy and safety profile in pediatric patients with severe chronic plaque psoriasis up to 1 year
    Bodemer, Christine
    Kaszuba, Andrzej
    Kingo, Kulli
    Tsianakas, Athanasios
    Morita, Akimichi
    Rivas, Enrique
    Papanastasiou, Philemon
    Patekar, Manmath
    Papavassilis, Charis
    Bruin, Gerard
    You, Ruquan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB59 - AB59
  • [28] Efalizumab for patients with moderate to severe plaque psoriasis - A randomized controlled trial
    Gordon, KB
    Papp, KA
    Hamilton, TK
    Walicke, PA
    Dummer, W
    Li, N
    Bresnahan, BW
    Menter, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23): : 3073 - 3080
  • [29] Efficacy and safety of efalizumab in patients with chronic moderate to severe plaque psoriasis: Results from a postapproval phase IIIb/IV study (control II)
    Lotti, Torello
    Licu, Daiana
    Chimenti, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB179 - AB179
  • [30] Combination of efalizumab and acitretin in chronic plaque psoriasis
    Gisondi, P.
    Girolomoni, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (02) : 247 - 248
12345